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prosperity of humanity. Potential microbial and chemical contaminants of drinking water have been 
identified by a joint effort between the World Health Organization (WHO) and the United Nations Children’s 
Fund (UNICEF), who together establish guidelines that define, in part, that the presence of Escherichia coli 
(E. coli) in drinking water is an indication of inadequate sanitation and a significant health risk. As E. coli 
is a nearly ubiquitous resident of mammalian gastrointestinal tracts, no detectable counts in 100 mL of 
drinking water is the standard used worldwide as an indicator of sanitation. The currently accepted EPA 
method relies on filtration, followed by growth on selective media, and requires 24–48 h from sample to 
results. In response, we developed a rapid bacteriophage-based detection assay with detection limit 
capabilities comparable to traditional methods in less than a quarter of the time. We coupled membrane 
filtration with selective enrichment using genetically engineered bacteriophages to identify less than 20 
colony forming units (CFU) E. coli in 100 mL drinking water within 5 h. The combination of membrane 
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Abstract: A sanitized drinking water supply is an unconditional requirement for public health and
the overall prosperity of humanity. Potential microbial and chemical contaminants of drinking water
have been identified by a joint effort between the World Health Organization (WHO) and the United
Nations Children’s Fund (UNICEF), who together establish guidelines that define, in part, that the
presence of Escherichia coli (E. coli) in drinking water is an indication of inadequate sanitation and
a significant health risk. As E. coli is a nearly ubiquitous resident of mammalian gastrointestinal
tracts, no detectable counts in 100 mL of drinking water is the standard used worldwide as an
indicator of sanitation. The currently accepted EPA method relies on filtration, followed by growth
on selective media, and requires 24–48 h from sample to results. In response, we developed a
rapid bacteriophage-based detection assay with detection limit capabilities comparable to traditional
methods in less than a quarter of the time. We coupled membrane filtration with selective enrichment
using genetically engineered bacteriophages to identify less than 20 colony forming units (CFU)
E. coli in 100 mL drinking water within 5 h. The combination of membrane filtration with phage
infection produced a novel assay that demonstrated a rapid, selective, and sensitive detection of
an indicator organism in large volumes of drinking water as recommended by the leading world
regulatory authorities.
Keywords: bacteriophage; drinking water; E.coli; rapid detection
1. Introduction
The United Nations has determined that every person has a fundamental human right to water
and sanitation [1]. Unfortunately, millions still lack access to potable water sources within reasonable
walking distances from their homes [2].Not only does microbial contamination of drinking water
contribute significantly to morbidity and mortality worldwide, it disproportionally affects low income
countries [3].Improper sanitation of drinking water sources is strongly correlated with the presence
of coliforms (a widely variable group of gram-negative rod shaped bacteria that possess a range
of biochemical attributes [4]). Escherichia coli (E. coli), which is a coliform, is also a near ubiquitous
resident of mammalian gastrointestinal tracts [5], and thus has been determined to be an appropriate
indicator of fecal pollution from warm-blooded animals. In 2015, almost 850 million people still lacked
Sensors 2020, 20, 1953; doi:10.3390/s20071953 www.mdpi.com/journal/sensors
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access to a basic drinking water source [6] of those 850 million people, children typically bear the
brunt of the disease burden, as their developing immune systems are dramatically less effective at
eradicating ingested coliforms in improperly sanitized drinking water [7]. The resulting diarrheal
disease typically results in severe dehydration, a condition that necessitates a clean drinking water
source for improvement in well-being. In addition, various strains of E. coli are responsible for nearly a
third of neonatal sepsis cases [8] and the majority of urinary tract infections worldwide [9].
Even though the detection of any indicator species will have inherent limitations and biases [10],
the detection of E. coli as an indication of poor sanitation has been widely successful in the improvement
of water supplies worldwide [2,11–14]. While standard culture-based techniques are reliable, results
require anywhere from 24 to 72 h [15,16], a relative eternity for a community water supply in need of
remediation [17].
The rapid detection of bacteria remains a significant challenge, and many research approaches
have been developed to help address this important public health issue [18]. One promising area
of rapid microbial detection assays are bacteriophage-based diagnostics [19]. Bacteriophages are
obligate bacteria-infecting viruses that have co-evolved with bacteria for most (if not all) of the more
3 billion years that bacteria have existed on the planet [20]. Reporter phages have been modified to
include an exogenous reporter gene in their genome. The newly created recombinant phage expresses
the exogenous cellular biomarker upon phage infection, in addition to new phage progeny [21].
Measurement of the reporter enzyme activity allows for correlation between signal output (e.g.,
absorbance, fluorescence, and luminescence) and estimation of the number of host organisms in the
sample over a certain threshold.
The field of bioluminescence has been advancing for 70 years, to where we now find
McElroy’s pioneering work [22] on the development and widespread implementation of NanoLuc
luciferase [23–33]. Luminescent reporter phages have been developed for the sensitive detection of
common foodborne pathogens such as Escherichia coli [24,34,35], Listeria monocytogenes [36], Salmonella
typhimurium [37], Mycobacterium tuberculosis [38], and Vibrio parahaemolyticus [39], among others [40–45].
The NanoLuc reporter is uniquely suited for sensitive detection assays, as it confers a low background
signal coupled with high dynamic range [33].
In addition, the orthogonality of the NanoGlo chemical substrate system [33] offers consistently
low background levels in a wide range of sample conditions, a characteristic enabling low-cost
implementation. An issue with previous systems was that as sensitivity increased, distinguishing
signals from noise became a major challenge in the establishment of the limit of detection.
The selective nature of phages has been well documented [46], and therefore our phage-based
detection assay is well suited in situations where indicators and/or pathogen detection is pertinent [47].
To create the recombinant phages used in our novel detection platform, an enzyme expression cassette
was inserted into a wild type phage genome to force expression of a heterologous reporter enzyme,
in addition to new phage progeny upon phage infection. The NanoLuc enzyme was selected as
the reporter enzyme, as it is more than 100x more active than its luminescent counterparts [33],
and this highly active reporter enzyme has already ben widely deployed in a variety of detection
assays [25,26,31,32], including bacteriophage-based schemes [24,48,49]. The NanoLuc enzyme was
further functionalized by genetically fusing a cellulose binding module (CBM) to the C-terminus of
the NanoLuc reporter gene. The CBM selected for this work (CBM2a) has previously been fused to
a dimeric reporter enzyme (alkaline phosphatase), which allows for successful immobilization on
cellulose while still retaining enzymatic activity [50]. In comparison, NanoLuc is a much smaller,
monomeric reporter that is frequently utilized as a genetic fusion tag.
Upon phage infection, the expression levels of the reporter enzyme have a direct effect upon
the limit of detection, as fewer cells are required to produce enough reporter enzyme for the signal
to rise above the detection limit. As a result, we modified the upstream regulatory regions of the
reporter enzyme cassette to determine the optimal sequences that permit the detection of the lowest
concentration of cells.
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Herein, we propose a rapid (5 h) bacteriophage-based approach for the sensitive detection of the
indicator bacteria Escherichia coli, the target of many regulatory requirements [51]. The novel detection
assay couples membrane filtration with bacteriophage infection to generate a luminescent signal when
viable Escherichia coli are present. The combination of sample concentration with heterologous reporter
enzyme expression upon bacteriophage infection produced a detection limit of less than 20 CFU in
100 mL of drinking water.
2. Materials & Methods
2.1. Materials & Reagents
NanoGlo (luminescent substrate) was purchased from Promega (Madison, WI, USA) and prepared
immediately prior to use. Regenerated cellulose filters (diameter 13 mm, pore size 0.2 µm) were fitted
within polycarbonate reusable syringe filter housings (Sartorious Stedim Biotech GmbH, Goettingen,
Germany) and autoclaved prior to use in detection assays. Assembled, autoclaved filters were fitted to
sterile single use syringes (100 mL, Wilburn Medical, Kernersville, NC, USA) to perform filtration. All
other reagents were purchased from Sigma Aldrich (St. Louis, MO, USA).
2.2. Bacterial Strains & Growth Conditions
Escherichia coli BL21 was obtained from ATCC (Manassas, VA, USA) and E. coli ECOR13, a reference
strain of E. coli isolated from a healthy human, was obtained from the Thomas. S. Whittam STEC
Center (East Lansing, MI, USA). Bacterial stocks were stored at −80 ◦C in 25% glycerol prior to use
and cultured in Lysogeny Bertani high salt (LB) broth and plated on LB agar. Overnight cultures of
E. coli BL21 and E. coli ECOR13 were cultivated in Luria-Bertani medium (12–16 h, 37 ◦C, 250 rpm).
The concentration of E. coli ECOR13 used in detection assays was determined by standard plate counts
on LB agar (24 h, 37 ◦C).
Bacteriophage T7 was propagated on E. coli BL21 using standard protocols. Briefly, an overnight
culture of E. coli BL21 was subcultured in LB (200 mL, 37 ◦C, 250 rpm, ~2 h) and grown to the
midexponential phase (OD600 = 0.6). Phages were added to the bacterial culture at a multiplicity of
infection (MOI) of 0.1, and incubated (37 ◦C, 250 rpm) until lysis was observed (~2 h). Cellular debris
was removed via centrifugation (3200× g, 10 min, 4 ◦C) before sterile filtration (0.22 µm). Phage particles
were precipitated by overnight incubation (4 ◦C, 18 h) with polyethylene glycol 6000 (PEG6000, 4%)
and sodium chloride (NaCl; 0.4 M), before ultracentrifugation (35,000× g, 120 min, 4 ◦C). Phages were
resuspended in phosphate buffered saline (1x PBS, pH 7.4) and stored at 4 ◦C. Standard double agar
overlay assays were used to enumerate phage samples [52]. Phage stock solutions used in detection
assays were diluted to 10 [9] PFU/mL in LB, sterile filtered (0.22 µm), and stored at 4 ◦C.
2.3. DNA Isolation
DNA was prepared in accordance with standard procedures [53]. Briefly, concentrated phage
stocks (5 mL, >10 [11] PFU/mL) were treated with sodium dodecyl sulfate (5 mL; 4%) at 70 ◦C for
20 min before cooling on ice. Potassium acetate (5 mL, 2.55 M, pH 4.8) was added, the samples were
centrifuged (10 min, 10,000× g, 4 ◦C), and the supernatant was applied to an anion exchange resin
(Qiagen Genomic Tip 100/G), in accordance with the manufacturer’s specifications.
2.4. Recombinant Phage Construction
The E. coli codon optimized NanoLuc-CBM reporter gene cassette was synthesized and cloned in
plasmid pUC57 (Genscript USA Inc.). The synthesized cassette was excised with restriction enzymes
EcoRI and HindIII n and ligated to the predigested T7 Select EcoRI/HindIII adaptor DNAs (Novagen).
The ligation mix was packaged in vitro using a T7 select packing extract and transduced into 300 µL
(OD600 0.6) of E. coli BL21 followed by 30 min incubation at 37 ◦C. Multiple dilutions of transduced
E. coli BL21 were mixed with LB-top agar (0.75 %) and poured over LB plates. Plates were incubated at
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30 ◦C overnight. Plates with the largest numbers of isolated plaques were selected. Individual plaques
were screened for the expression of the NanoLuc-CBM cassette by adding NanoGlo substrate (Promega,
Madison WI, USA), followed by imaging for 30 s (Rebel T6, Canon, Melville NY, USA) in a dark box
(LTE-13, Newport Corporation, Irvine, CA, USA). The presence of luminescence on plaque periphery
indicated the successful introduction of the NanoLuc-CBM cassette in the T7 phage. One individual
plaque was picked, and this was followed by two rounds of plaque purification and amplification
on E. coli BL21 [52], and referred to as NRGp5. The insertion of the NanoLuc-CBM cassette in the T7
phage was confirmed by PCR and its integrity confirmed by Sanger sequencing.
2.5. Phage Characterization
The genomes from the NRGp5 phages were isolated and submitted for sequencing. Characterization of
the phage infection was compared to the original T7 Select. The phage host E. coli ECOR13 was grown
from the stationary phase in LB media (3 h, 37 ◦C, 250 rpm) using 24 well microplates (Greiner Bio-One
North America Inc., Monroe, NC, USA). The optical density at 600 nm (OD600) was determined at
periodic time intervals to observe the growth of the bacterial cells. Phage addition (negative control,
107 PFU/mL T7 Select, or 107 PFU/mL NRGp5) took place at 180 min and the optical density (OD600)
was monitored for 300 min using a Synergy Neo2 microplate reader (Biotek Instruments, Winooski,
VT, USA).
The luminescence during the phage infections was monitored for a negative control, T7 Select, and
NRGp5, as well as a previously developed NRGp4 [48]. Luminescent signals were measured using the
same microplate reader (Biotek Instruments, Winooski, VT, USA) in sterile 24-well suspension culture
plates (Cellstar, Greiner Bio-One, Monroe, NC, USA) with a 0.1 s integration time. To approximate
growth conditions in the detection assay, the host E. coli ECOR13 was grown from the stationary phase
in LB supplemented with NanoGlo (3 h, 37 ◦C, 250 rpm). Phage addition took place at 180 minutes
and luminescence was measured at 30 min intervals for 300 min.
2.6. Dose Response
The sensitivity of phage NRGp5 to different concentrations of bacteria in the growth media was
evaluated. Phage NRGp5 (107 PFU/mL) was added to serial dilutions of mid-exponential phase E. coli
ECOR13 (0 to 105 CFU/mL) and incubated (1.5 h, 37 ◦C) to allow the phage infection to proceed.
Aliquots were mixed 1:1 with NanoGlo substrate and luminescence was measured on a Synergy Neo2
microplate reader (Biotek Instruments, Winooski, VT, USA). Viable bacterial concentrations were
confirmed using standard plate counts.
2.7. Infection of Non-Viable Cells
The ability of phage NRGp5 to differentiate between viable and nonviable bacterial cells was
evaluated by treating identical cultures with either alcohol (inactivation) or a biological buffer (control)
before phage infection. Briefly, E. coli ECOR13 was harvested at the mid-exponential phase (OD600 = 0.5),
separated into identical aliquots, and centrifuged (3000× g, 5 min). The cell pellet was resuspended in
either ethanol (70%) or phosphate buffered saline (PBS; 1×), and incubated at room temperature for
10 min. The cells were pelleted again (3000× g, 5 min), resuspended in sterile autoclaved drinking
water (100 mL, 20 ◦C), and used as analytical samples for the phage-based diagnostic assay.
2.8. Phage-Based Syringe Filter Detection Assay
An illustrative schematic for the detection scheme is detailed in Figure 1. Drinking water was
autoclaved to account for any natural flora before aliquots (100 mL) were deliberately spiked with
known concentrations of E. coli ECOR13. Samples were then passed through 0.22 µm regenerated
cellulose filters (Sartorius Stedim Biotech GmbH, Goettingen, Germany) to separate the bacteria. The
filters were removed and incubated on LB media (3 h, 37 ◦C) in order to resuscitate the bacteria. Phage
NRGp5 (107 PFU/mL) was applied to the enriched bacteria on the filter and incubated (1.5 h, 37 ◦C) for
Sensors 2020, 20, 1953 5 of 12
the expression of the luminescent reporter. The filters were fully submerged in NanoGlo substrate
and luminescence was measured every 12 s for 5 min in a spectrophotometer to capture peak signal
generation. The variability of the blank was used to calculate the limit of detection using the standard
method of adding three times the standard deviation of the blank to the mean blank value.Sensors 2019, 19, x FOR PEER REVIEW 6 of 14 
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a reporter enzyme consisting of NanoLuc (blue) and a carbohydrate binding module (orange) with 
specificity to cellulose. (d) The fusion enzyme binds to the cellulose filter and the luminescent activity 
can then be determined. 
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3.1 Recombinant Phage Construction 
NanoLuc, was selected as a preferred reporter because it is a small, highly active, monomeric 
enzyme [33]. The 19 kDa luciferase was genetically fused to a carbohydrate binding module to create 
a 31 kDa fusion enzyme. This novel fusion reporter has demonstrated the simultaneous capability to 
generate a luminescent signal while specifically bound to a cellulosic substrate. The whole phage 
genome sequencing results of reporter phage NRGp5 revealed no mutations to the insertion cassette, 
as well as no insertions, deletions, or significant mutations outside of the cloning site. 
3.2 Phage Characterization 
Initial screening for the successful insertion of the reporter gene was determined by visualizing 
the luminescence of phage plaques. Reporter gene expression was confirmed via long exposure 
photography of double overlay plaque assays where NanoGlo substrate was directly applied to the 
isolated plaques. Luminescent plaques were isolated and propagated to create high-titer stocks for 
downstream use, including detection assays and DNA isolation for whole genome sequencing. The 
ability of phage NRGp5 to infect and lyse indicator bacteria was directly compared to the original T7 
Select, to evaluate if the addition of the reporter gene had a measurable effect on the apparent fitness 
of the phage. As seen in Figure 2, the lysis profiles of the phages are similar, indicating that the 
reporter gene insertion had a minimal effect on the ability of the phage to lyse infected bacteria. 
Furthermore, the burst size of phage NRGp5 was similar to that of NRGp4 and T7 Select (data not 
shown). The genetic location of the NanoLuc-CBM gene insertion was immediately downstream of 
Figure 1. Assay format for the detection of E. coli in drinking water. (a) The water is filtered through a
0.22 µm cellulose filter in order to separate the bacteria. (b) The filter is then removed from the housing
and placed on LB media in order to resuscitate the trapped bacteria. (c) Following the application of the
engineered phages (grey), an infection cycle results in the expression and release of a reporter enzyme
consisting of NanoLuc (blue) and a carbohydrate binding module (orange) with specificity to cellulose.
(d) The fusion enzyme binds to the cellulose filter and the luminescent activity can then be determined.
3. Results & Discussion
3.1. Recombinant Phage Construction
NanoLuc, was selected as a preferred reporter because it is a small, highly active, monomeric
enzyme [33]. The 19 kDa luciferase was genetically fused to a carbohydrate binding module to create
a 31 kDa fusion enzyme. This novel fusion reporter has demonstrated the simultaneous capability
to gen rate a luminescent signal while specifi ll bound to a cellulosic su strate. The whole ph ge
genome sequencing results of reporter phage NRGp5 revealed no mutations to the insertion cassette,
as well as no insertions, deletions, or significant mutations outside of the cloning site.
3.2. Phag Characterization
Initial screening for the successful insertion of the reporter gene was determined by visualizing
the luminescence of phage plaques. Reporter gene expression was confirmed via long exposure
photography of double overlay plaque assays where NanoGlo substrate was directly applied to the
isolated plaqu s. Luminescent plaq es w e isolated and propagated to create high-titer tocks for
downstream use, including detection assays and DNA isolation for whole genome sequencing. The
ability of phage NRGp5 to infect and lyse indicator bacteria was directly compared to the original T7
Select, to evaluate if the addition of the reporter gene had a measurable effect on the apparent fitness of
the phage. As seen in Figure 2, the lysis profiles of the phages are similar, indicating that the reporter
gene insertion had a minimal effect on the ability of the phage to lyse infected bacteria. Furthermore,
the burst size of phage NRGp5 was similar to hat of NRGp4 and T7 Select (data not shown). The
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genetic location of the NanoLuc-CBM gene insertion was immediately downstream of the capsid gene,
as confirmed by whole genome sequencing. The genetic insertion served to increase the genome size
of the wild type T7Select by less than 3% (37.3 kb vs. 38.3 kb) leaving it with a genome still smaller
(~38 kb) than that of its 39.7 kb wild-type counterpart [54].
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Figure 2. Phages (NRGp5 or T7 Select) were added to individual cultures of E. coli (ECOR13) after 3 h
of enrichment. The E. coli in samples without phages added continued to the exponential phase, while
the application of phages resulted in a decline in optical density after about two hours.
During infection, T7 DNA is replicated in concatemers and successful phage maturation relies on
the specific recognition and cleavage of cos sites located at the termini of each genomic copy. If the
ge etic insertion is too large, then progeny phages will be unable to fit the genome into the finite s ace
provided within the capsid.
Packing of the modified genome into the capsid was not expected to cause a loss in fitness as larger
reporter genes have previously been inserted into T7 with no apparent lack of fitness [55,56]. As seen in
Figure 3, only cul ures infect with phage NRGp4 or NRGp5 produced luminescent signals abov the
limit of detection. While changes to the promoter an ribosome binding sites upstream of the reporter
only served to decrease the luminescence signal during the infection of identical cultures (data not
shown), removal of the pelB N-terminal secretion signal used in phage NRGp4 [48] produced nearly a
half log increase in signal intensity (Figure 3) when identical cultures were infected and compared.
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Figure 3. Luminescence was measured from E. coli samples with and without the phages of T7
Select, which did not contain a gene for a reporter enzyme, NRGp4, but which contained a gene for
NanoLuc-CBM, and NRGp5, which contained an optimized NanoLuc-CBM gene. It can be seen that the
reporter genes resulted in luminescence with the optimized gene providing a higher signal. Error bars
indicate the standard deviation of three biological triplicates and the limit of detection (lowest positive
signal) was calculated as the negative control + 3x the standard deviation. The standard deviation
for phages NRGp4 and NRGp5 was too low to produce visible error bars at the final time points of
the assay.
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The results suggest that the newly developed reporter phage NRGp5 is a viable candidate for use
as a more sensitive biosensor element in a syringe-based detection assay.
In order to make an initial estimate of the potential to detect low concentrations of CFUs, NRGp5
was used to infect a known high concentration of E. coli ECOR13. The lysate was then serially diluted
and tested (Figure 4). From this we can see that the lysate from an equivalent to low numbers of E. coli
were detectable. As seen in Figure 4, the results suggested a relatively linear response (R2 = 0.9941)
over a broad range of bacterial concentrations 100–105 CFU/mL. Furthermore, because drinking water
often undergoes treatment steps in order to kill potentially harmful pathogens, the ability to distinguish
between viable and non-viable bacterial is critical for reliable results. Given that phages utilize the
genetic machinery of the host bacteria for successful replication, it was not expected that NRGp5 could
replicate in non-viable cells. In order to determine if the assay is able to distinguish between viable
and non-viable bacterial cells, E. coli ECOR13 cells were treated with 70% ethanol and washed prior to
analysis. As demonstrated in Figure 5, only phages added to non-ethanol treated cells were able to
produce luminescence following substrate addition, while bacterial cells treated with ethanol did not
produce luminescence following phage addition.
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Figure 4. NRGp5 was added at a high multiplicity of infection (MOI) to varying concentrations of E. coli
ECOR13. The luminescence of the lysate resulting from the infections was measured following the
addition of substrate. The results suggest relative relationship (R2 = 0.9941) between the concentration
of E. coli and the generation of the luminescent signal over several orders of magnitude.
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Figure 5. To demonstrate the ability of the phage-based assay to distinguish between viable and
non-viable E. coli ECOR13 cells, 103 bacterial cells were exposed to either 70% ethanol or PBS, and
washed. The cells were then either infected with NRGp5 or incubated without phages. The only
cell treatment regime to display luminescence following incubation and substrate addition was the
non-ethanol treated E. coli ECOR13 infected with NRGp5.
3.3. Phage-Based Syringe Filter Detection Assay
After determining the sensitivity of the phage to produce a measurable signal in bulk solution we
introduced a sample concentration to further improve the performance of the phage-based assay. The
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addition of a syringe filter to the detection scheme served to decrease the limit of detection several
orders of magnitude from ~100 CFU/mL to less than 20 CFU/100 mL (Figure 6). The inoculation levels
used to determine the aforementioned detection limits were low enough to achieve the fractional
recovery of positive results as recommended by multiple validation procedures [57,58]. As indicated
by the horizontal error bars in Figure 6 (error bars crossing an axis are not displayed) recovery of
positive samples at low inoculation levels was possible in only approximately 80% of the samples.
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Figure 6. Performance of the phage-based syringe filter detection assay compared to standard plate
counts. Water (100 mL) was processed through a syringe filter (0.22 um, regenerated cellulose) where
bacteria (E. coli ECOR13) were enriched prior to the addition of phage NRGp5. Reporter enzymes were
expressed, immobilized onto the cellulose filter, and luminescence was measured.
In addition to fractional recovery of positive samples, other considerations towards methodology
validation were considered to ensure the robustness of the newly developed detection assay. Recovery
and enrichment steps were included prior to phage infection to provide injured and/or stressed bacterial
cells an opportunity to recover. The test was performed using target organisms (E. coli) in the intended
product (drinking water) where the organism has limited growth potential from the lack of available
nutri nts. Finally, our novel phage-based method was directly compared to a gold standard reference
culture-based method to ensure accurate quantitation of bacterial i oculum.
Our novel detection assay realized multiple improvements over previously developed technologies
and approaches the limits of detection of standard culture-based techniques in only 5 h, compared to
24–48 h for the latter metho s. Phage-based det ction schemes have the potential o realize further
improvements to the limit of detection at these bacterial concentrations while maintaining a shorter
assay time than standard reference methods.
4. Conclusions
The presented research displays a specific, rapid, and effective detection assay for indicators of
E. coli in large drinking water samples based on heterologous enzyme expression via phage infection.
Phages have multiple properties that make them excellent candidates as biorecognition elements for
the sensitive and rapid detection of bacteria. Not only are phages incredibly species specific, they are
also capable of differentiating between live and non-viable cells.
We have demonstrated the successful insertion of a reporter enzyme cassette into a phage genome
to create the reporter phage NRGp5. This recombinant phage forced the overexpression of a highly
active bifunctional reporter enzyme that was immobilized onto a regenerated cellulose membrane filter,
which facilitated the rapid detection of low concentrations of indicator bacterial E. coli cells. While a
cocktail of phages is typically eeded to cover a broad host range, his phage-based platfo m offers
portability and low cost with rapid results. Improvements in enzymatic activity and bacterial expression
as well as phage host range will serve to create a robust and sensitive detection assay with potential to
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dramatically improve the lives of people around the world through the rapid microbiological analysis
of vital drinking water supplies.
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